BellBrook Labs Overview

  • Year Founded
  • 2002

Year Founded

  • Status
  • Private

  • Employees
  • 19

Employees

  • Latest Deal Type
  • Grant

  • Latest Deal Amount
  • $390K

  • Investors
  • 11

BellBrook Labs General Information

Description

Developer of a screening tool designed to accelerate drug discovery and biological research. The company's proprietary technology was developed to move new targets into HTS rapidly, and to streamline selectivity profiling within a target family, enabling researchers to accelerate the discovery of effective therapies.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 1232 Fourier Drive
  • Suite 115
  • Madison, WI 53711
  • United States
+1 (608)
Primary Industry
Discovery Tools (Healthcare)
Other Industries
Drug Discovery
Biotechnology
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • 1232 Fourier Drive
  • Suite 115
  • Madison, WI 53711
  • United States
+1 (608)

BellBrook Labs Timeline

2021202220232024
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

BellBrook Labs Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
13. Grant 01-Aug-2021 $390K Completed Generating Revenue
12. Grant 20-Apr-2021 Completed Generating Revenue
11. Grant 01-Jan-2019 Completed Generating Revenue
10. Later Stage VC 29-Nov-2018 Completed Generating Revenue
9. Accelerator/Incubator Completed Generating Revenue
8. Grant 01-Jun-2015 Completed Generating Revenue
7. Seed Round 15-Jun-2012 Completed Generating Revenue
6. Grant 01-Jan-2009 Completed Generating Revenue
5. Later Stage VC 01-Nov-2008 $1.64M $3.29M Completed Generating Revenue
4. Later Stage VC 09-May-2008 $150K $1.65M Completed Generating Revenue
To view BellBrook Labs’s complete valuation and funding history, request access »

BellBrook Labs Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a screening tool designed to accelerate drug discovery and biological research. The company's proprietary t
Discovery Tools (Healthcare)
Madison, WI
19 As of 2024

Vancouver, Canada
 

Farmingdale, NY
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

BellBrook Labs Competitors (55)

One of BellBrook Labs’s 55 competitors is AbCellera, a Formerly VC-backed company based in Vancouver, Canada.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
AbCellera Formerly VC-backed Vancouver, Canada
EpiGentek Corporation Farmingdale, NY
Abcam Corporate Backed or Acquired Cambridge, United Kingdom
Allele Biotechnology Venture Capital-Backed San Diego, CA
ProMab Biotechnologies Corporate Backed or Acquired Richmond, CA
You’re viewing 5 of 55 competitors. Get the full list »

BellBrook Labs Patents

BellBrook Labs Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2022218787-A1 Inhibitors of cgas activity as therapeutic agents Pending 11-Feb-2021
EP-4291188-A1 Inhibitors of cgas activity as therapeutic agents Pending 11-Feb-2021
CA-3206520-A1 Inhibitors of cgas activity as therapeutic agents Pending 11-Feb-2021
JP-2024506904-A Inhibitors of cgas activity as therapeutic agents Pending 11-Feb-2021
US-20240174684-A1 Inhibitors of cgas activity as therapeutic agents Pending 11-Feb-2021 C07D491/048
To view BellBrook Labs’s complete patent history, request access »

BellBrook Labs Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

BellBrook Labs Investors (11)

Investor Name Investor Type Holding Investor Since Participating Rounds
National Institute on Alcohol Abuse and Alcoholism Government
Wisconsin Economic Development Government Minority
National Institute of Standards and Technology Government
U.S. Department of Commerce Government
National Institute Of Allergy and Infectious Diseases Government
You’re viewing 5 of 11 investors. Get the full list »

BellBrook Labs FAQs

  • When was BellBrook Labs founded?

    BellBrook Labs was founded in 2002.

  • Where is BellBrook Labs headquartered?

    BellBrook Labs is headquartered in Madison, WI.

  • What is the size of BellBrook Labs?

    BellBrook Labs has 19 total employees.

  • What industry is BellBrook Labs in?

    BellBrook Labs’s primary industry is Discovery Tools (Healthcare).

  • Is BellBrook Labs a private or public company?

    BellBrook Labs is a Private company.

  • What is BellBrook Labs’s current revenue?

    The current revenue for BellBrook Labs is .

  • How much funding has BellBrook Labs raised over time?

    BellBrook Labs has raised $3.87M.

  • Who are BellBrook Labs’s investors?

    National Institute on Alcohol Abuse and Alcoholism, Wisconsin Economic Development, National Institute of Standards and Technology, U.S. Department of Commerce, and National Institute Of Allergy and Infectious Diseases are 5 of 11 investors who have invested in BellBrook Labs.

  • Who are BellBrook Labs’s competitors?

    AbCellera, EpiGentek, Abcam, Allele Biotechnology, and ProMab Biotechnologies are some of the 55 competitors of BellBrook Labs.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »